Children's Cancer Group, China

This phase 3 trial tests a modified chemotherapy regimen for 150 Chinese children and teens newly diagnosed with lymphoblastic lymphoma. The goal is to improve event-free survival compared to earlier results. Participants receive a combination of drugs including prednisone, vincr…

This phase 4 study tests a modified chemotherapy regimen (based on a U.S. protocol) in 200 Chinese children and teens with newly diagnosed Hodgkin lymphoma. Depending on risk level, patients receive 4 to 6 cycles of chemotherapy, with or without low-dose radiation. The goal is to…

This study tests whether adding 4 injections of rituximab to stronger chemotherapy can help children and teens with advanced B-cell lymphoma live longer without the disease coming back. About 200 participants will receive the new regimen and be compared to past results. The goal …

This study tests a modified chemotherapy regimen (ALCL99) in 172 Chinese children and teens with high-risk anaplastic large cell lymphoma. The goal is to see if the new plan improves 3-year survival without the cancer coming back, while also tracking side effects. Participants re…